Search Results - "spondylitis"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    High mortality in cervical fracture with ankylosing spondylitis : case reports by Goh, Kian Liang, Zakaria@Mohamad, Zamzuri, Mohd Amin, Azril, Awang, Mohd Shukrimi, Mohd Yusof, Nazri

    Published 2011
    “…Ankylosing spondylitis is a systemic inflammatory disease which may predispose the cervical spine to fracture, subluxation or dislocation. …”
    Get full text
    Get full text
    Get full text
  2. 2
  3. 3
  4. 4

    Establishing the association between ankylosing spondylitis and its comorbidities based on their shared pathways by Alhassan Usman Bello, Sarahani Harun, Nor Afiqah-Aleng, Rajalingham Sakthiswary, Zetiazura Mohamed-Hussein

    Published 2024
    “…Ankylosing spondylitis (AS) is an autoimmune and inflammatory arthritis associated with various comorbidities, such as axial spondyloarthritis (axSpA), cardiovascular disease (CD), Guillain-Barre syndrome (GBS), rheumatic fever (RF), and vasculitis (Vs). …”
    Get full text
    Get full text
  5. 5
  6. 6

    Prevalence of sleep disturbance in patients with ankylosing spondylitis: a systematic review and meta-analysis by Salari, Nader, Sadeghi, Narges, Hosseinian-Far, Amin, Hasheminezhad, Razie, Khazaie, Habibolah, Shohaimi, Shamarina, Mohammadi, Masoud

    Published 2023
    “…Background: Ankylosing Spondylitis (AS) patients face several challenges due to the nature of the disease and its physical and psychological complications. …”
    Get full text
    Get full text
  7. 7

    Tc-99m NIDP and Tc-99m HMPAO labelled leukocyte scans in tuberculous spondylitis by Mohamad, Abdul R, Shuaib, Ibrahim L, Razak, Ruslan, Abdullah, Abdul H

    Published 1999
    “…A study was undertaken to assess the pattern of uptake on bone and labelled leukocyte scans in tuberculous spondylitis. Nine consecutive newly diagnosed cases were studied with Tc-99m MDP bone scans and Tc-99m HMPAO labelled leukocyte scans.The patients had basic laboratory investigations, plain chest and spine radiographs and computed tomography of the spine. …”
    Get full text
    Get full text
  8. 8
  9. 9
  10. 10
  11. 11

    Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: A report from the Australian Rheumatology Association database by Oldroyd, J., Schachna, L., Buchbinder, R., Staples, M., Murphy, B., Bond, M., Briggs, Andrew, Lassere, M., March, L.

    Published 2009
    “…To compare the baseline characteristics of a population-based cohort of patients with ankylosing spondylitis (AS) commencing biological therapy to the reported characteristics of bDMARD randomised controlled trials (RCTs) participants. …”
    Get full text
  12. 12
  13. 13

    Biologics in rheumatic diseases by Abdullah, Hilmi

    Published 2017
    “…This talk was about the use of biological therapies such as Tumour Necrosis Factor Inhibitor in the treatment of inflammatory arthritides such as Rheumatoid Arthritis, psoriatic arthritis and ankylosing spondylitis…”
    Get full text
    Get full text
  14. 14

    Same, but is it similar? a case report by Awang, Mohd Shukrimi, Abdul Rashid, Amran, Mohd Ghalib, Razali, Che Ahmad, Aminudin, Harun, Nora

    Published 2007
    “…Tuberculous spondylitis may be imposable to differentiate from pyogenic vertebral osteomyelitis and other primary or metatastatic tumours based on clinical and radiographic findings. …”
    Get full text
    Get full text
  15. 15

    Imaging features of mycotic aortic aneurysms by Zhang, N., Xiong, W., Li, Y., Mao, Q., Xu, S., Zhu, J., Sun, Zhonghua, Sun, L.

    Published 2021
    “…Enlarged lymph nodes are often found adjacent to the aneurysm, while iliopsoas abscess (IPA), spondylitis, and aortic fistulas are commonly associated complications. …”
    Get full text
  16. 16

    CT imaging manifestations of tuberculous aortic aneurysm by Xing, X.N., Sun, Zhonghua, Chen, L., Zhang, N., Xiong, W., Li, Y.

    Published 2022
    “…Of the 17 patients, 12 (71%) had calcification; 14 (82%) had intraluminal thrombus; 12 (71%) showed enlarged lymph nodes, which were closely related to the aneurysm; and 9 (52.94%) had tuberculous spondylitis including TB of the thoracic lumbar and lumbosacral spine. …”
    Get full text
  17. 17

    Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization by Sammour, Rana M.F, Taher, Muhammad, Mahmood, Syed

    Published 2019
    “…The application of this system can improve the bioavailability of aceclofenac that is used for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The present study is intended to develop an optimized proniosomal aceclofenac formula by the use of different carriers. …”
    Get full text
    Get full text
  18. 18

    A case series of spinal infections following COVID-19: a delayed complication by Mohamed Ramlee, Fadzrul Abbas, Harun, Mohd Hezery, Nagaretnam, Vinodharan, Teck, Siang Lim, Aris, Hasry Faris, Chor, Ngee Tan

    Published 2022
    “…The final case is a young female who was diagnosed with severe T5 tuberculous spondylitis and presented with a complete sensory and motor deficit from T5 below. …”
    Get full text
  19. 19

    Optimization of aceclofenac proniosomes by using different carriers, Part 1 : development and characterization by Sammour, Rana M.F., Taher, Muhammad, Chatterjee, Bappaditya, Shahiwala, Aliasgar, Mahmood, Syed

    Published 2019
    “…The application of this system can improve the bioavailability of aceclofenac that is used for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The present study is intended to develop an optimized proniosomal aceclofenac formula by the use of different carriers. …”
    Get full text
    Get full text
  20. 20

    Optimization of aceclofenac proniosomes by using different carriers, part 1: development and characterization by MF Sammour, Rana, Bakhtiar, Muhammad Taher, Chatterjee, Bappaditya, Shahiwala, Aliasgar, Mahmood, Syed

    Published 2019
    “…The application of this system can improve the bioavailability of aceclofenac that is used for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The present study is intended to develop an optimized proniosomal aceclofenac formula by the use of different carriers. …”
    Get full text
    Get full text
    Get full text